Pharma

Your Article Summary

See Latest Articles

Retigabine Regulatory Update
GlaxoSmithKline, 11/03/09

GlaxoSmithKline and Valeant Pharmaceuticals International announced that, on October, they filed a New Drug Application with the US Food and Drug Administration and a Marketing Authorisation Application with the European Medicines Agency, for retigabine, used as adjunctive therapy to treat adult epilepsy patients with partial–onset seizures.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09

See All of Drug/Product Approvals

Today in Regulatory Issues...keeping you current

Receive free subspecialty "5-minute updates" via email

New Drug Application Filed for Eldecalcitol, An Active Vitamin D3 Derivative
Chugai Pharmaceutical Co., 11/04/09

Trends in prescribing and self-poisoning in relation to UK regulatory authority warnings against use of SSRI antidepressants in under-18-year-olds
British Journal of Clinical Pharmacology, 11/02/09

Waste in the U.S. Healthcare System Pegged at $700 Billion in Report from Thomson Reuters
AMN Healthcare, 10/27/09

See All of Regulatory Issues